1. Home
  2. RRX vs BIO Comparison

RRX vs BIO Comparison

Compare RRX & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regal Rexnord Corporation

RRX

Regal Rexnord Corporation

N/A

Current Price

$202.54

Market Cap

9.0B

Sector

N/A

ML Signal

N/A

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

N/A

Current Price

$270.40

Market Cap

7.2B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
RRX
BIO
Founded
1955
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
7.2B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
RRX
BIO
Price
$202.54
$270.40
Analyst Decision
Buy
Strong Buy
Analyst Count
10
4
Target Price
$208.90
$358.50
AVG Volume (30 Days)
971.7K
296.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
0.70%
N/A
EPS Growth
42.86
N/A
EPS
4.20
N/A
Revenue
$3,257,100,000.00
N/A
Revenue This Year
$4.17
$2.51
Revenue Next Year
$10.74
$3.17
P/E Ratio
$47.89
$9.72
Revenue Growth
5.21
N/A
52 Week Low
$90.56
$211.43
52 Week High
$229.30
$343.12

Technical Indicators

Market Signals
Indicator
RRX
BIO
Relative Strength Index (RSI) 51.08 39.98
Support Level $136.02 $266.71
Resistance Level $227.65 $290.01
Average True Range (ATR) 8.92 7.01
MACD -4.46 0.54
Stochastic Oscillator 46.83 20.91

Price Performance

Historical Comparison
RRX
BIO

About RRX Regal Rexnord Corporation

Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The four operating segments include Commercial Systems, Industrial Systems, Climate Solutions, and Motion Control Solutions.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: